Trial Profile
A MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, ACTIVE- AND PLACEBO-CONTROLLED TRIAL TO INVESTIGATE THE EFFICACY AND TOLERABILITY OF NEBICAPONE IN PARKINSON'S DISEASE PATIENTS WITH "WEARING-OFF" PHENOMENON TREATED WITH LEVODOPA/CARBIDOPA OR LEVODOPA/BENSERAZIDE
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Nebicapone (Primary) ; Entacapone
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Bial
- 05 Nov 2010 New trial record.